Barrick Gold (USA) Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.210 |
| EPS actual | $0.200 |
| EPS Surprise | -4.76% |
| Revenue estimate | 64.212M |
| Revenue actual | 59.39M |
| Revenue Surprise | -7.51% |
| Release date | Mar 12, 2026 |
| EPS estimate | $0.200 |
| EPS actual | $0.230 |
| EPS Surprise | 15.00% |
| Revenue estimate | 55.382M |
| Revenue actual | 71.899M |
| Revenue Surprise | 29.82% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.180 |
| EPS actual | $0.200 |
| EPS Surprise | 11.11% |
| Revenue estimate | 55.765M |
| Revenue actual | 62.975M |
| Revenue Surprise | 12.93% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.160 |
| EPS actual | $0.220 |
| EPS Surprise | 37.50% |
| Revenue estimate | 54.378M |
| Revenue actual | 56.225M |
| Revenue Surprise | 3.40% |
Last 4 Quarters for Barrick Gold (USA)
Below you can see how ABX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $17.95 |
| EPS estimate | $0.160 |
| EPS actual | $0.220 |
| EPS surprise | 37.50% |
| Date | Price |
|---|---|
| Sep 21, 2021 | $18.49 |
| Sep 22, 2021 | $18.45 |
| Sep 23, 2021 | $18.23 |
| Sep 24, 2021 | $18.03 |
| Sep 27, 2021 | $17.95 |
| Dec 30, 2025 | $8.29 |
| Dec 31, 2025 | $8.55 |
| Jan 02, 2026 | $7.92 |
| Jan 05, 2026 | $8.05 |
| 4 days before | -2.92% |
| 4 days after | -55.15% |
| On release day | -53.82% |
| Change in period | -56.46% |
| Release date | Nov 06, 2025 |
| Price on release | $17.95 |
| EPS estimate | $0.180 |
| EPS actual | $0.200 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Sep 21, 2021 | $18.49 |
| Sep 22, 2021 | $18.45 |
| Sep 23, 2021 | $18.23 |
| Sep 24, 2021 | $18.03 |
| Sep 27, 2021 | $17.95 |
| Dec 30, 2025 | $8.29 |
| Dec 31, 2025 | $8.55 |
| Jan 02, 2026 | $7.92 |
| Jan 05, 2026 | $8.05 |
| 4 days before | -2.92% |
| 4 days after | -55.15% |
| On release day | -53.82% |
| Change in period | -56.46% |
| Release date | Mar 12, 2026 |
| Price on release | $9.85 |
| EPS estimate | $0.200 |
| EPS actual | $0.230 |
| EPS surprise | 15.00% |
| Date | Price |
|---|---|
| Mar 06, 2026 | $9.83 |
| Mar 09, 2026 | $9.63 |
| Mar 10, 2026 | $10.31 |
| Mar 11, 2026 | $10.10 |
| Mar 12, 2026 | $9.85 |
| Mar 13, 2026 | $9.80 |
| Mar 16, 2026 | $9.92 |
| Mar 17, 2026 | $10.09 |
| Mar 18, 2026 | $9.44 |
| 4 days before | 0.203% |
| 4 days after | -4.16% |
| On release day | -0.508% |
| Change in period | -3.97% |
| Release date | May 07, 2026 |
| Price on release | $9.37 |
| EPS estimate | $0.210 |
| EPS actual | $0.200 |
| EPS surprise | -4.76% |
| Date | Price |
|---|---|
| May 01, 2026 | $9.44 |
| May 04, 2026 | $9.19 |
| May 05, 2026 | $9.26 |
| May 06, 2026 | $9.44 |
| May 07, 2026 | $9.37 |
| May 08, 2026 | $9.08 |
| May 11, 2026 | $9.23 |
| May 12, 2026 | $9.34 |
| May 13, 2026 | $9.25 |
| 4 days before | -0.742% |
| 4 days after | -1.28% |
| On release day | -3.09% |
| Change in period | -2.01% |
Barrick Gold (USA) Earnings Call Transcript Summary of Q1 2026
Abacus Global Management reported a strong start to 2026 driven by sizable fundraising, robust origination activity and improved cash generation. Management raised full-year adjusted net income guidance to $100M–$106M (adjusted EPS $1.00–$1.05) and provided Q2 adjusted net income guidance of $24M–$26M ($0.24–$0.26). Key operational highlights: $288M raised into longevity funds in Q1 (following $275M in Q4), nearly 9,000 qualified policies reviewed in Q1, $163.6M deployed in policy originations during the quarter, and portfolio metrics (turnover 1.9x, average realized gain 26%, seasoned asset life ~46 months / insured age 88) above targets. Financially, total revenue grew 34.6% to $59.4M, adjusted net income rose 16.6% to $20.1M, adjusted EBITDA grew 33.3% to $32.7M with a 55% adjusted EBITDA margin, and GAAP net income was $7.3M. Operating cash flow was $91.7M in Q1 2026 (vs. -$61.6M in Q1 2025), reflecting monetizations, fund wind-down (LMA Income II returned capital), and operating leverage. The LMA Income II fund reached term and returned capital on time, with ~1/3 of investors extending or reinvesting; that fund’s conclusion reduced reported balance-sheet debt by ~$76.7M (a deconsolidation effect). Management emphasized two growth initiatives: (1) a strategic/distribution partnership with Manning & Napier expected to produce early results in Q2, and (2) an active securitization program with a potential second transaction targeted for late Q2/early Q3 to recycle capital and broaden funding. Capital allocation priorities: the core Life Solutions balance sheet is self-funding (approx. $450M in liquid managed assets), the company views itself as under-levered (recourse debt/EBITDA ~2x vs. capacity to ~4x), intends to grow fee-bearing AUM (targeting $30B AUM by 2028 with ~50/50 organic/inorganic mix), and will remain disciplined on M&A (seeking accretive deals) while opportunistically using buybacks (about half of a $20M authorization used). Management reiterated that improved demand has compressed purchase discount rates, which they view as a positive (higher asset values, expanded long-term spreads). Overall, the quarter provided evidence of strong demand, high-quality origination, cash flow convertibility, improved reported leverage from fund deconsolidation, and clear strategic levers (distribution alliance, securitizations, M&A, AUM growth) to scale the business.
Sign In
Buy ABX